Literature DB >> 358805

Suramin: with special reference to onchocerciasis.

F Hawking.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 358805     DOI： 10.1016/s1054-3589(08)60486-x

Source DB:  PubMed          Journal:  Adv Pharmacol Chemother        ISSN： 0065-3144


× No keyword cloud information.
  50 in total

1.  [Effect of suramin on proliferation and migration of lens epithelial cells in vitro].

Authors:  P W Rieck; J Kriegsch; C Jaeckel; C Hartmann
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

2.  Phase II trial of suramin in patients with metastatic renal cell carcinoma.

Authors:  R Dreicer; D C Smith; R D Williams; W A See
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

3.  Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors.

Authors:  T P Fleming; T Matsui; C J Molloy; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.

Authors:  Arndt Vogel; Joseph E Aslan; Holger Willenbring; Christian Klein; Milton Finegold; Howard Mount; Gary Thomas; Markus Grompe
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

5.  Nontoxic suramin as a chemosensitizer in patients: dosing nomogram development.

Authors:  Danny Chen; Sae Heum Song; M Guillaume Wientjes; Teng Kuang Yeh; Liang Zhao; Miguel Villalona-Calero; Gregory A Otterson; Rhonda Jensen; Michael Grever; Anthony J Murgo; Jessie L-S Au
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

6.  The effect of suramin on healing adult rodent dermal wounds.

Authors:  J Chamberlain; M Shah; M W Ferguson
Journal:  J Anat       Date:  1995-02       Impact factor: 2.610

7.  The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site.

Authors:  Hugh P Morgan; Iain W McNae; Matthew W Nowicki; Wenhe Zhong; Paul A M Michels; Douglas S Auld; Linda A Fothergill-Gilmore; Malcolm D Walkinshaw
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

8.  Suppression of polymorphonuclear leukocyte bactericidal activity by suramin.

Authors:  E Roilides; P Paschalides; A Freifeld; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

9.  Influence of suramin on the expression of Fc receptors and other markers on human monocytes and U937 cells, and on their phagocytic properties.

Authors:  C Schiller; A Spittler; M Willheim; Z Szépfalusi; H Agis; M Köller; M Peterlik; G Boltz-Nitulescu
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

10.  A novel bioluminescent protease assay using engineered firefly luciferase.

Authors:  Susan S Wigdal; Jessica L Anderson; Gediminas J Vidugiris; John Shultz; Keith V Wood; Frank Fan
Journal:  Curr Chem Genomics       Date:  2008-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.